2023年(nian)3月28日，理(li)邦仪(yi)器发布了(le)2022年(nian)年(nian)度报(bao)告。财报(bao)显示，2022年(nian)，理(li)邦仪(yi)器实现(xian)(xian)营业(ye)(ye)收(shou)入17.42亿元(yuan)，同(tong)(tong)(tong)比(bi)增(zeng)(zeng)长(zhang) 6.48%；归(gui)属于(yu)(yu)上(shang)市公司(si)(si)股(gu)东的净(jing)利润为(wei)(wei)2.33亿元(yuan)，同(tong)(tong)(tong)比(bi)增(zeng)(zeng)长(zhang)0.67%；归(gui)属于(yu)(yu)上(shang)市公司(si)(si)股(gu)东的扣除(chu)非经常性损(sun)益的净(jing)利润为(wei)(wei)2亿元(yuan)，同(tong)(tong)(tong)比(bi)增(zeng)(zeng)长(zhang)4.94%。公司(si)(si)整体营收(shou)较去年(nian)同(tong)(tong)(tong)期实现(xian)(xian)增(zeng)(zeng)长(zhang)，病人监(jian)护业(ye)(ye)务(wu)(wu)与去年(nian)同(tong)(tong)(tong)期相比(bi)跌(die)幅大(da)幅收(shou)窄，超声(sheng)线(xian)业(ye)(ye)务(wu)(wu)、体外诊断业(ye)(ye)务(wu)(wu)、妇幼健康业(ye)(ye)务(wu)(wu)、心电诊断及(ji)智慧医疗业(ye)(ye)务(wu)(wu)均(jun)同(tong)(tong)(tong)比(bi)实现(xian)(xian)增(zeng)(zeng)长(zhang)，其中(zhong)超声(sheng)产品线(xian)同(tong)(tong)(tong)比(bi)增(zeng)(zeng)幅超过30%，体外诊断业(ye)(ye)务(wu)(wu)同(tong)(tong)(tong)比(bi)增(zeng)(zeng)幅超过19%。
2023年(nian)3月28日，理邦仪器(qi)发布了2022年(nian)年(nian)度报(bao)告(gao)。财报(bao)显(xian)示，2022年(nian)，理邦仪器(qi)实现(xian)营业(ye)(ye)收(shou)入(ru)17.42亿元，同(tong)(tong)比(bi)增(zeng)(zeng)(zeng)长 6.48%；归属于上(shang)市公(gong)司股东的净利润为2.33亿元，同(tong)(tong)比(bi)增(zeng)(zeng)(zeng)长0.67%；归属于上(shang)市公(gong)司股东的扣除非经常性损益的净利润为2亿元，同(tong)(tong)比(bi)增(zeng)(zeng)(zeng)长4.94%。公(gong)司整体营收(shou)较去(qu)年(nian)同(tong)(tong)期实现(xian)增(zeng)(zeng)(zeng)长，病人(ren)监(jian)护(hu)业(ye)(ye)务与去(qu)年(nian)同(tong)(tong)期相(xiang)比(bi)跌(die)幅大幅收(shou)窄，超(chao)声线业(ye)(ye)务、体外诊断业(ye)(ye)务、妇幼健康业(ye)(ye)务、心电诊断及智慧医疗业(ye)(ye)务均同(tong)(tong)比(bi)实现(xian)增(zeng)(zeng)(zeng)长，其(qi)中超(chao)声产品线同(tong)(tong)比(bi)增(zeng)(zeng)(zeng)幅超(chao)过(guo)30%，体外诊断业(ye)(ye)务同(tong)(tong)比(bi)增(zeng)(zeng)(zeng)幅超(chao)过(guo)19%。
2023年3月28日，理(li)邦(bang)仪(yi)器发(fa)布了2022年年度报(bao)(bao)告(gao)。财报(bao)(bao)显(xian)示，2022年，理(li)邦(bang)仪(yi)器实现(xian)(xian)营业收入17.42亿(yi)(yi)(yi)元(yuan)(yuan)(yuan)，同(tong)(tong)比增(zeng)(zeng)(zeng)长(zhang) 6.48%；归(gui)属(shu)于上(shang)市(shi)公(gong)司股东的净(jing)利润(run)为2.33亿(yi)(yi)(yi)元(yuan)(yuan)(yuan)，同(tong)(tong)比增(zeng)(zeng)(zeng)长(zhang)0.67%；归(gui)属(shu)于上(shang)市(shi)公(gong)司股东的扣除非经(jing)常性损益的净(jing)利润(run)为2亿(yi)(yi)(yi)元(yuan)(yuan)(yuan)，同(tong)(tong)比增(zeng)(zeng)(zeng)长(zhang)4.94%。公(gong)司整体营收较去年同(tong)(tong)期实现(xian)(xian)增(zeng)(zeng)(zeng)长(zhang)，病(bing)人监护业务(wu)(wu)与去年同(tong)(tong)期相比跌幅(fu)大幅(fu)收窄(zhai)，超声(sheng)线(xian)业务(wu)(wu)、体外(wai)诊断(duan)业务(wu)(wu)、妇幼健康业务(wu)(wu)、心电诊断(duan)及智慧医疗(liao)业务(wu)(wu)均同(tong)(tong)比实现(xian)(xian)增(zeng)(zeng)(zeng)长(zhang)，其中超声(sheng)产品线(xian)同(tong)(tong)比增(zeng)(zeng)(zeng)幅(fu)超过(guo)30%，体外(wai)诊断(duan)业务(wu)(wu)同(tong)(tong)比增(zeng)(zeng)(zeng)幅(fu)超过(guo)19%。
